Healthcare Providers and Services
Company Overview of McKesson Specialty Health
McKesson Specialty Health distributes specialty drugs to physicians and other healthcare providers in the United States. It offers pharmaceuticals and medical-surgical supplies for use in oncology, rheumatology, gastroenterology, nephrology or dialysis, ophthalmology, urology, internal medicine, and other specialty. McKesson Specialty Health was formerly known as Mckesson Specialty Care Solutions. The company is based in Scottsdale, Arizona. McKesson Specialty Health operates as a subsidiary of McKesson Corporation.
4343 North Scottsdale Road
Scottsdale, AZ 85251
Key Executives for McKesson Specialty Health
Chief Medical Officer and Senior Vice President
Chief Information Officer and Senior Vice President of Information & Technology Services
Medical Director of Oncology Services
Compensation as of Fiscal Year 2017.
McKesson Specialty Health Key Developments
McKesson Specialty Health and The US Oncology Network Expand Agreement With The National Comprehensive Cancer Network, Adding New Disease States to Value Pathways
Jun 14 17
McKesson Specialty Health and The US Oncology Network expanded their agreement with the National Comprehensive Cancer Network® (NCCN®), adding five additional disease states to Value Pathways powered by NCCN. Value Pathways powered by NCCN are evidence-based treatment recommendations for oncology delivered through McKesson Specialty Health’s clinical quality and regimen support system, Clear Value PlusSM. New cancers added include bladder, esophageal, gastric, kidney, and myelodysplastic syndromes (MDS), making Clear Value Plus even more robust. The point-of-care support tool now provides detailed information on 27 different disease states. The expanded relationship also calls for the addition of up to 15 more disease states in the next three years and more in the future, ensuring that the more than 1,500 providers utilizing Clear Value Plus will have quick and easy access to the very latest information and research on each cancer. Both Value Pathways powered by NCCN and NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) are integrated into the clinical workflow and Electronic Health Records by Clear Value Plus. NCCN Guidelines are the most comprehensive and most frequently updated clinical practice guidelines available in any area of medicine, and they are recognized across the industry as the gold standard in cancer care. Clear Value Plus is the only technology that includes the full logic of NCCN Guidelines®. The rigorous logic of these Guidelines is embedded as the foundational evidence source within Clear Value Plus, supplemented by the collaboratively-developed Value Pathways. Grounded in clinical quality and evidence-based medicine, Value Pathways powered by NCCN helps ensure patients receive high-quality care that offers the best opportunity for positive outcomes, while also recognizing the importance of value in determining appropriate treatment options.
Varian Medical Systems and McKesson Specialty Health Ink Deal for Advanced Radiotherapy Equipment and Software
Oct 31 16
Varian Medical Systems and McKesson Specialty Health reported a strategic agreement for the deployment and servicing of Varian advanced radiotherapy equipment and software over a three-year period across The US Oncology Network and Vantage Oncology affiliated sites of care. The multiyear agreement delivers significant value to oncology providers in The US Oncology Network, which now operates the large system of radiotherapy facilities in the U.S. following the acquisition of Vantage Oncology earlier this year.
McKesson Specialty Health Unveils New Solution to Support Community-Based Oncology Practices
May 18 16
McKesson Specialty Health has unveiled a comprehensive solution that includes services, expertise and technology to support community-based oncology practices participating in The Center for Medicare and Medicaid Innovation's, or CMMI, Oncology Care Model, or OCM. The OCM is a new, voluntary payment and care delivery model that attempts to improve the effectiveness and efficiency of cancer care by aligning financial incentives and accountability for episodes of care involving chemotherapy. To participate, practices must meet new quality metric requirements (collecting them and sharing them with CMS). Financial and operational success will require transformative changes to how care is delivered and documented. McKesson Specialty Health's OCM solutions are currently being used and tested at pilot sites in The US Oncology Network.
Similar Private Companies By Industry
Recent Private Companies Transactions